Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Harrington Cleveland

Showing results (41-50 of 48) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 48 results.
Addictive Behaviors|August 22, 2016
Daily sleep quality affects drug craving, partially through indirect associations with positive affect, in patients in treatment for nonmedical use of prescription drugsDavid M Lydon-Staley, H Harrington Cleveland, Andrew S Huhn, et al.
Development and Psychopathology|February 3, 2015
The conditioning of intervention effects on early adolescent alcohol use by maternal involvement and dopamine receptor D4 (DRD4) and serotonin transporter linked polymorphic region (5-HTTLPR) genetic variantsH Harrington Cleveland, Gabriel L Schlomer, David J Vandenbergh, et al.
Child Development|November 19, 2016
Extending Previous cG×I Findings on 5-HTTLPR's Moderation of Intervention Effects on Adolescent Substance Misuse InitiationGabriel L Schlomer, H Harrington Cleveland, Mark E Feinberg, et al.
Nicotine & Tobacco Research : Official Journal of the Society for Research on Nicotine and Tobacco|May 6, 2015
An Adolescent Substance Prevention Model Blocks the Effect of CHRNA5 Genotype on Smoking During High SchoolDavid J Vandenbergh, Gabriel L Schlomer, H Harrington Cleveland, et al.
Prevention Science : the Official Journal of the Society for Prevention Research|February 3, 2017
Transactions Between Substance Use Intervention, the Oxytocin Receptor (OXTR) Gene, and Peer Substance Use Predicting Youth Alcohol UseH Harrington Cleveland, Amanda M Griffin, Pedro S A Wolf, et al.
Research Square|June 12, 2025
Efficacy of the GLP-1 receptor agonist, semaglutide, in abstinence from illicit and nonprescribed opioids in an outpatient population with treatment-refractory OUD: A randomized, double-blind, placebo-controlled clinical trial protocolChristopher S Freet, Kirsten Shuler, Sarah Kawasaki, et al.
Addiction Science & Clinical Practice|October 31, 2025
Efficacy of the GLP-1 receptor agonist, semaglutide, in abstinence from illicit and nonprescribed opioids in an outpatient population with OUD: a randomized, double-blind, placebo-controlled clinical trial protocolChristopher S Freet, Kirsten Shuler, Sarah Kawasaki, et al.
Addiction Science & Clinical Practice|July 26, 2024
Ecological momentary assessment and cue-elicited drug craving as primary endpoints: study protocol for a randomized, double-blind, placebo-controlled clinical trial testing the efficacy of a GLP-1 receptor agonist in opioid use disorderChristopher S Freet, Brianna Evans, Timothy R Brick, et al.
Pageof 5

Showing results (41-50 of 48) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 48 results.
Addictive Behaviors|August 22, 2016
Daily sleep quality affects drug craving, partially through indirect associations with positive affect, in patients in treatment for nonmedical use of prescription drugsDavid M Lydon-Staley, H Harrington Cleveland, Andrew S Huhn, et al.
Development and Psychopathology|February 3, 2015
The conditioning of intervention effects on early adolescent alcohol use by maternal involvement and dopamine receptor D4 (DRD4) and serotonin transporter linked polymorphic region (5-HTTLPR) genetic variantsH Harrington Cleveland, Gabriel L Schlomer, David J Vandenbergh, et al.
Child Development|November 19, 2016
Extending Previous cG×I Findings on 5-HTTLPR's Moderation of Intervention Effects on Adolescent Substance Misuse InitiationGabriel L Schlomer, H Harrington Cleveland, Mark E Feinberg, et al.
Nicotine & Tobacco Research : Official Journal of the Society for Research on Nicotine and Tobacco|May 6, 2015
An Adolescent Substance Prevention Model Blocks the Effect of CHRNA5 Genotype on Smoking During High SchoolDavid J Vandenbergh, Gabriel L Schlomer, H Harrington Cleveland, et al.
Prevention Science : the Official Journal of the Society for Prevention Research|February 3, 2017
Transactions Between Substance Use Intervention, the Oxytocin Receptor (OXTR) Gene, and Peer Substance Use Predicting Youth Alcohol UseH Harrington Cleveland, Amanda M Griffin, Pedro S A Wolf, et al.
Research Square|June 12, 2025
Efficacy of the GLP-1 receptor agonist, semaglutide, in abstinence from illicit and nonprescribed opioids in an outpatient population with treatment-refractory OUD: A randomized, double-blind, placebo-controlled clinical trial protocolChristopher S Freet, Kirsten Shuler, Sarah Kawasaki, et al.
Addiction Science & Clinical Practice|October 31, 2025
Efficacy of the GLP-1 receptor agonist, semaglutide, in abstinence from illicit and nonprescribed opioids in an outpatient population with OUD: a randomized, double-blind, placebo-controlled clinical trial protocolChristopher S Freet, Kirsten Shuler, Sarah Kawasaki, et al.
Addiction Science & Clinical Practice|July 26, 2024
Ecological momentary assessment and cue-elicited drug craving as primary endpoints: study protocol for a randomized, double-blind, placebo-controlled clinical trial testing the efficacy of a GLP-1 receptor agonist in opioid use disorderChristopher S Freet, Brianna Evans, Timothy R Brick, et al.
Pageof 5